Literature DB >> 33186702

The treatment of asthma using the Chinese Materia Medica.

Jun-Xi Liu1, Yang Zhang2, Hong-Yu Yuan2, Jun Liang3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Asthma is a costly global health problem that negatively influences the quality of life of patients. The Chinese Materia Medica (CMM) contains remedies that have been used for the treatment of asthma for millennia. This article strives to systematically summarize the current research progress so that more comprehensive examinations of various databases related to CMM anti-asthma drugs, can be performed, so as to sequentially provide effective basic data for development and application of anti-asthma drugs based on the CMM.
MATERIALS AND METHODS: The research data published over the past 20 years for asthma treatment based on traditional CMM remedies were retrieved and collected from libraries and online databases (PubMed, ScienceDirect, Elsevier, Spring Link, Web of Science, PubChem Compound, Wan Fang, CNKI, Baidu, and Google Scholar). Information was also added from classic CMM, literature, conference papers on classic herbal formulae, and dissertations (PhD or Masters) based on traditional Chinese medicine.
RESULTS: This review systematically summarizes the experimental studies on the treatment of asthma with CMM, covering the effective chemical components, typical asthma models, important mechanisms and traditional anti-asthma CMM formulae. The therapy value of the CMM for anti-asthma is clarified, and the original data and theoretical research foundation are provided for the development of new anti-asthmatic data and research for the CMM.
CONCLUSIONS: Substantial progress against asthma has been made through relevant experimental research based on the CMM. These advances improved the theoretical basis of anti-asthma drugs for CMM and provided a theoretical basis for the application of a asthma treatment that is unique. By compiling these data, it is expected that the CMM will now contain a clearer mechanism of action and a greater amount of practical data that can be used for future anti-asthma drug research.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chinese Materia Medica (CMM); active ingredients; asthma; formula

Year:  2020        PMID: 33186702     DOI: 10.1016/j.jep.2020.113558

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Sophoraflavanone G from Sophora flavescens Ameliorates Allergic Airway Inflammation by Suppressing Th2 Response and Oxidative Stress in a Murine Asthma Model.

Authors:  Meng-Chun Wang; Wen-Chung Huang; Li-Chen Chen; Kuo-Wei Yeh; Chwan-Fwu Lin; Chian-Jiun Liou
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

2.  Qufeng Xuanbi Formula Ameliorates Airway Remodeling in Asthmatic Mice by Suppressing Airway Smooth Muscle Cell Proliferation through MEK/ERK Signaling Pathway.

Authors:  Bohan Wang; Lingling Tang; Suofang Shi; Ying Yang; Xianhong Sun; Xiaona Zhang; Chunyang Liu; Li Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-09       Impact factor: 2.629

Review 3.  The Role and Mechanisms of Traditional Chinese Medicine for Airway Inflammation and Remodeling in Asthma: Overview and Progress.

Authors:  Bo-Wen Zhou; Hua-Man Liu; Xin-Hua Jia
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

4.  Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology.

Authors:  Li Shen; Jinmiao Lu; Guangfei Wang; Cheng Wang; Zhiping Li
Journal:  Comput Math Methods Med       Date:  2022-09-05       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.